Widespread Brain Structural Alterations Seen in Conduct Disorders

2024-07-26
FRIDAY, July 26, 2024 -- There are widespread brain structural alterations apparent in conduct disorders, mostly in surface area, according to a study published in the August issue of The Lancet Psychiatry.
Yidian Gao, Ph.D., from the University of Birmingham in the United Kingdom, and colleagues examined brain structural correlates of conduct disorders among those aged 18 years or younger. Individual participant data were collected from 1,185 young people with conduct disorder and 1,253 typically developing young people (mean age, 13.5 years).
The researchers found that the conduct disorder group had lower surface area in 26 cortical regions and lower total surface area relative to typically developing young people. Differences were seen in cortical thickness in the caudal anterior cingulate cortex and the banks of the superior temporal sulcus. Smaller amygdala, nucleus accumbens, thalamus, and hippocampus volumes were also seen in the conduct disorder group. After adjustment for attention-deficit/hyperactivity disorder comorbidity or intelligence quotient, most differences remained significant. There were no group-by-sex or group-by-age interactions seen. Between Diagnostic and Statistical Manual of Mental Disorders-defined conduct disorder subtypes, few differences were found. However, more widespread differences were seen for individuals with high callous-unemotional traits versus controls than for those with low callous-unemotional traits.
"These findings provide further evidence that brain alterations could contribute to conduct disorder," the authors write. "This underrecognized disorder warrants greater consideration in research, including longitudinal studies exploring neurodevelopmental trajectories and additional subtyping approaches."
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。